Arrowhead Pharmaceuticals, Inc. (ARWR)
USD 9.99
(-2.54%)
USD 9.99
(-2.54%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -205.27 Million USD | -16.31% |
| 2022 | -176.49 Million USD | -25.31% |
| 2021 | -140.84 Million USD | -66.58% |
| 2020 | -84.55 Million USD | -224.39% |
| 2019 | 67.97 Million USD | 224.84% |
| 2018 | -54.45 Million USD | -58.38% |
| 2017 | -34.38 Million USD | 57.93% |
| 2016 | -81.72 Million USD | 11.11% |
| 2015 | -91.94 Million USD | -56.81% |
| 2014 | -58.63 Million USD | -88.26% |
| 2013 | -31.14 Million USD | -47.42% |
| 2012 | -21.12 Million USD | -575.19% |
| 2011 | -3.12 Million USD | 45.81% |
| 2010 | -5.77 Million USD | 70.1% |
| 2009 | -19.3 Million USD | 28.72% |
| 2008 | -27.08 Million USD | 9.5% |
| 2007 | -29.93 Million USD | -57.56% |
| 2006 | -18.99 Million USD | -186.76% |
| 2005 | -6.62 Million USD | -165.32% |
| 2004 | -2.49 Million USD | -2521.79% |
| 2003 | -95.23 Thousand USD | 61.32% |
| 2002 | -246.2 Thousand USD | -32.5% |
| 2001 | -185.82 Thousand USD | -35.09% |
| 2000 | -137.55 Thousand USD | -123.2% |
| 1999 | 593 Thousand USD | 1248.79% |
| 1998 | -51.62 Thousand USD | 93.96% |
| 1997 | -854.53 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | -170.79 Million USD | -36.31% |
| 2024 Q1 | -132.86 Million USD | -21.14% |
| 2024 Q2 | -125.3 Million USD | 5.69% |
| 2023 Q1 | -41.81 Million USD | 51.35% |
| 2023 Q4 | -109.67 Million USD | -6.54% |
| 2023 Q2 | 48.67 Million USD | 216.42% |
| 2023 Q3 | -102.94 Million USD | -311.5% |
| 2023 FY | -205.27 Million USD | -16.31% |
| 2022 Q3 | -71.18 Million USD | -260.44% |
| 2022 Q4 | -85.94 Million USD | -20.73% |
| 2022 Q1 | -62.87 Million USD | 0.79% |
| 2022 Q2 | 44.36 Million USD | 170.57% |
| 2022 FY | -176.49 Million USD | -25.31% |
| 2021 Q4 | -63.37 Million USD | -111.78% |
| 2021 Q1 | -20.73 Million USD | 57.19% |
| 2021 FY | -140.84 Million USD | -66.58% |
| 2021 Q2 | -26.81 Million USD | -29.36% |
| 2021 Q3 | -29.92 Million USD | -11.58% |
| 2020 Q1 | -2.67 Million USD | -122.84% |
| 2020 Q3 | -13.61 Million USD | 31.38% |
| 2020 FY | -84.55 Million USD | -224.39% |
| 2020 Q4 | -48.43 Million USD | -255.83% |
| 2020 Q2 | -19.83 Million USD | -641.87% |
| 2019 Q1 | 12.03 Million USD | 211.86% |
| 2019 Q3 | 20.33 Million USD | -14.9% |
| 2019 FY | 67.97 Million USD | 224.84% |
| 2019 Q2 | 23.89 Million USD | 98.53% |
| 2019 Q4 | 11.7 Million USD | -42.44% |
| 2018 Q1 | -13.19 Million USD | -22.99% |
| 2018 FY | -54.45 Million USD | -58.38% |
| 2018 Q3 | -15.6 Million USD | -4.85% |
| 2018 Q4 | -10.76 Million USD | 31.04% |
| 2018 Q2 | -14.88 Million USD | -12.77% |
| 2017 Q3 | -5.51 Million USD | 8.65% |
| 2017 Q1 | -12.08 Million USD | 45.61% |
| 2017 FY | -34.38 Million USD | 57.93% |
| 2017 Q4 | -10.73 Million USD | -94.43% |
| 2017 Q2 | -6.04 Million USD | 50.0% |
| 2016 Q2 | -20.81 Million USD | -8.05% |
| 2016 Q4 | -22.22 Million USD | -14.42% |
| 2016 Q1 | -19.26 Million USD | 22.14% |
| 2016 FY | -81.72 Million USD | 11.11% |
| 2016 Q3 | -19.42 Million USD | 6.7% |
| 2015 Q2 | -28.68 Million USD | -27.06% |
| 2015 FY | -91.94 Million USD | -56.81% |
| 2015 Q1 | -22.57 Million USD | -0.65% |
| 2015 Q3 | -15.93 Million USD | 44.44% |
| 2015 Q4 | -24.74 Million USD | -55.27% |
| 2014 Q1 | -10.62 Million USD | 22.38% |
| 2014 Q3 | -11.62 Million USD | 16.59% |
| 2014 Q4 | -22.43 Million USD | -92.89% |
| 2014 FY | -58.63 Million USD | -88.26% |
| 2014 Q2 | -13.94 Million USD | -31.18% |
| 2013 Q1 | -4.61 Million USD | 13.16% |
| 2013 Q2 | -6.75 Million USD | -46.46% |
| 2013 Q3 | -6.07 Million USD | 10.05% |
| 2013 Q4 | -13.69 Million USD | -125.24% |
| 2013 FY | -31.14 Million USD | -47.42% |
| 2012 FY | -21.12 Million USD | -575.19% |
| 2012 Q3 | -7.99 Million USD | -49.79% |
| 2012 Q1 | -2.48 Million USD | 10.48% |
| 2012 Q2 | -5.33 Million USD | -114.65% |
| 2012 Q4 | -5.31 Million USD | 33.51% |
| 2011 FY | -3.12 Million USD | 45.81% |
| 2011 Q4 | -2.77 Million USD | -52.56% |
| 2011 Q3 | -1.81 Million USD | -162.64% |
| 2011 Q2 | 2.9 Million USD | 302.08% |
| 2011 Q1 | -1.43 Million USD | 28.26% |
| 2010 Q4 | -2 Million USD | -440.11% |
| 2010 FY | -5.77 Million USD | 70.1% |
| 2010 Q3 | -371.05 Thousand USD | 79.99% |
| 2010 Q2 | -1.85 Million USD | -20.0% |
| 2010 Q1 | -1.54 Million USD | 55.35% |
| 2009 Q4 | -3.46 Million USD | -36.83% |
| 2009 FY | -19.3 Million USD | 28.72% |
| 2009 Q1 | -8.03 Million USD | 7.25% |
| 2009 Q2 | -5.28 Million USD | 34.13% |
| 2009 Q3 | -2.52 Million USD | 52.19% |
| 2008 FY | -27.08 Million USD | 9.5% |
| 2008 Q4 | -8.65 Million USD | -15.41% |
| 2008 Q3 | -7.5 Million USD | -31.74% |
| 2008 Q1 | -5.23 Million USD | 30.89% |
| 2008 Q2 | -5.69 Million USD | -8.81% |
| 2007 FY | -29.93 Million USD | -57.56% |
| 2007 Q2 | -6.17 Million USD | -66.54% |
| 2007 Q1 | -3.7 Million USD | 57.77% |
| 2007 Q3 | -12.47 Million USD | -102.1% |
| 2007 Q4 | -7.57 Million USD | 39.31% |
| 2006 FY | -18.99 Million USD | -186.76% |
| 2006 Q1 | -3.13 Million USD | -16.41% |
| 2006 Q2 | -3.1 Million USD | 0.97% |
| 2006 Q3 | -3.97 Million USD | -27.93% |
| 2006 Q4 | -8.77 Million USD | -120.92% |
| 2005 Q3 | -3.03 Million USD | -572.39% |
| 2005 Q4 | -2.69 Million USD | 11.25% |
| 2005 Q1 | -1.53 Million USD | -4.03% |
| 2005 Q2 | 642.76 Thousand USD | 141.83% |
| 2005 FY | -6.62 Million USD | -165.32% |
| 2004 Q4 | -1.47 Million USD | -131.43% |
| 2004 Q3 | -638.18 Thousand USD | -2223.83% |
| 2004 Q1 | -205.93 Thousand USD | -290.44% |
| 2004 Q2 | 30.04 Thousand USD | 114.59% |
| 2004 FY | -2.49 Million USD | -2521.79% |
| 2003 FY | -95.23 Thousand USD | 61.32% |
| 2003 Q4 | 108.13 Thousand USD | 302.08% |
| 2003 Q3 | -53.51 Thousand USD | 48.92% |
| 2003 Q2 | -104.76 Thousand USD | -132.3% |
| 2003 Q1 | -45.09 Thousand USD | 46.77% |
| 2002 Q4 | -84.72 Thousand USD | 3.82% |
| 2002 FY | -246.2 Thousand USD | -32.5% |
| 2002 Q1 | -63.25 Thousand USD | -3.78% |
| 2002 Q2 | -10.15 Thousand USD | 83.95% |
| 2002 Q3 | -88.08 Thousand USD | -767.56% |
| 2001 Q3 | -32.64 Thousand USD | 36.47% |
| 2001 FY | -185.82 Thousand USD | -35.09% |
| 2001 Q2 | -51.38 Thousand USD | -25.84% |
| 2001 Q1 | -40.83 Thousand USD | -217.34% |
| 2001 Q4 | -60.94 Thousand USD | -86.68% |
| 2000 Q2 | -54.09 Thousand USD | 10.9% |
| 2000 Q1 | -60.71 Thousand USD | -21.42% |
| 2000 FY | -137.55 Thousand USD | -123.2% |
| 2000 Q3 | -57.55 Thousand USD | -6.39% |
| 2000 Q4 | 34.8 Thousand USD | 160.47% |
| 1999 FY | 593 Thousand USD | 1248.79% |
| 1999 Q2 | -20 Thousand USD | 0.0% |
| 1999 Q4 | -50 Thousand USD | -107.35% |
| 1999 Q3 | 680 Thousand USD | 3500.0% |
| 1999 Q1 | -20 Thousand USD | 0.0% |
| 1998 Q4 | -20 Thousand USD | 0.0% |
| 1998 Q3 | - USD | 100.0% |
| 1998 FY | -51.62 Thousand USD | 93.96% |
| 1998 Q2 | -10 Thousand USD | 0.0% |
| 1997 FY | -854.53 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | -51.92 Million USD | -295.33% |
| Jaguar Health, Inc. | -41.3 Million USD | -397.034% |
| Keros Therapeutics, Inc. | -152.99 Million USD | -34.174% |
| Longboard Pharmaceuticals, Inc. | -54.42 Million USD | -277.191% |
| Alnylam Pharmaceuticals, Inc. | -440.24 Million USD | 53.372% |
| Ligand Pharmaceuticals Incorporated | 52.15 Million USD | 493.594% |
| ContextLogic Inc. | -317 Million USD | 35.244% |
| MiMedx Group, Inc. | 67.43 Million USD | 404.386% |
| MEI Pharma, Inc. | 17.77 Million USD | 1254.657% |
| AlloVir, Inc. | -190.41 Million USD | -7.802% |
| Novavax, Inc. | -545.06 Million USD | 62.339% |
| Aptorum Group Limited | -2.82 Million USD | -7167.28% |
| Ardelyx, Inc. | -66.06 Million USD | -210.707% |
| Psyence Biomedical Ltd. | -51.15 Million USD | -301.249% |
| Vaxcyte, Inc. | -402.26 Million USD | 48.97% |
| Precigen, Inc. | -95.9 Million USD | -114.042% |
| Pharming Group N.V. | -10.54 Million USD | -1846.104% |
| Phathom Pharmaceuticals, Inc. | -201.59 Million USD | -1.827% |
| Pieris Pharmaceuticals, Inc. | -24.54 Million USD | -736.389% |
| Rigel Pharmaceuticals, Inc. | -25.09 Million USD | -718.122% |
| Avidity Biosciences, Inc. | -212.22 Million USD | 3.273% |
| TransCode Therapeutics, Inc. | -18.54 Million USD | -1006.837% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -743.389% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -743.389% |
| Bicycle Therapeutics plc | -180.66 Million USD | -13.623% |
| Sangamo Therapeutics, Inc. | -257.83 Million USD | 20.384% |
| Sol-Gel Technologies Ltd. | -27.23 Million USD | -653.635% |
| Acelyrin, Inc. | -381.64 Million USD | 46.213% |
| SELLAS Life Sciences Group, Inc. | -37.34 Million USD | -449.746% |
| Sensei Biotherapeutics, Inc. | -34.1 Million USD | -501.962% |
| Senti Biosciences, Inc. | -92.91 Million USD | -120.918% |
| Stoke Therapeutics, Inc. | -104.69 Million USD | -96.062% |
| AbCellera Biologics Inc. | -146.39 Million USD | -40.217% |
| Alaunos Therapeutics, Inc. | -35.14 Million USD | -484.163% |
| BioXcel Therapeutics, Inc. | -179.05 Million USD | -14.645% |
| Entrada Therapeutics, Inc. | -6.68 Million USD | -2970.681% |
| Chimerix, Inc. | -82.09 Million USD | -150.046% |
| VistaGen Therapeutics, Inc. | -29.36 Million USD | -599.118% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -911.655% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.6 Million USD | -360.224% |
| Viracta Therapeutics, Inc. | -51.05 Million USD | -302.043% |
| Elevation Oncology, Inc. | -45.7 Million USD | -349.14% |
| Alkermes plc | 355.75 Million USD | 157.701% |
| Fortress Biotech, Inc. | -60.63 Million USD | -238.531% |
| Fortress Biotech, Inc. | -60.63 Million USD | -238.531% |
| Agenus Inc. | -245.76 Million USD | 16.474% |
| HOOKIPA Pharma Inc. | -81.58 Million USD | -151.624% |
| Dyadic International, Inc. | -6.79 Million USD | -2920.766% |
| ImmuCell Corporation | -5.77 Million USD | -3454.793% |
| Eton Pharmaceuticals, Inc. | -936 Thousand USD | -21831.09% |
| IDEAYA Biosciences, Inc. | -112.96 Million USD | -81.722% |
| Lantern Pharma Inc. | -15.96 Million USD | -1186.061% |
| Immix Biopharma, Inc. | -15.42 Million USD | -1230.704% |
| Incyte Corporation | 597.59 Million USD | 134.35% |
| IO Biotech, Inc. | -86.08 Million USD | -138.462% |
| Janux Therapeutics, Inc. | -58.29 Million USD | -252.143% |
| Inhibikase Therapeutics, Inc. | -19.02 Million USD | -978.755% |
| Outlook Therapeutics, Inc. | -58.98 Million USD | -248.026% |
| Syros Pharmaceuticals, Inc. | -164.57 Million USD | -24.731% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -2314.716% |
| Barinthus Biotherapeutics plc | -73.34 Million USD | -179.868% |
| Madrigal Pharmaceuticals, Inc. | -373.63 Million USD | 45.059% |
| Sorrento Therapeutics, Inc. | -572.84 Million USD | 64.166% |
| NextCure, Inc. | -62.72 Million USD | -227.272% |
| Ocuphire Pharma, Inc. | -9.98 Million USD | -1955.628% |
| Onconetix, Inc. | -37.4 Million USD | -448.721% |
| Oncternal Therapeutics, Inc. | -39.47 Million USD | -419.96% |
| Opthea Limited | -220.24 Million USD | 6.796% |
| PDS Biotechnology Corporation | -42.94 Million USD | -378.026% |
| PureTech Health plc | -65.69 Million USD | -212.457% |
| Pyxis Oncology, Inc. | -73.79 Million USD | -178.188% |
| Seer, Inc. | -86.27 Million USD | -137.926% |
| Salarius Pharmaceuticals, Inc. | -12.54 Thousand USD | -1636510.647% |
| Clearside Biomedical, Inc. | -32.48 Million USD | -531.907% |
| Telomir Pharmaceuticals, Inc. Common Stock | -13.07 Million USD | -1470.358% |
| VYNE Therapeutics Inc. | -28.45 Million USD | -621.478% |
| Wave Life Sciences Ltd. | -57.51 Million USD | -256.919% |
| Xeris Biopharma Holdings, Inc. | -62.25 Million USD | -229.733% |
| C4 Therapeutics, Inc. | -132.49 Million USD | -54.933% |
| ChromaDex Corporation | -4.93 Million USD | -4057.047% |
| TRACON Pharmaceuticals, Inc. | -3.58 Million USD | -5621.154% |
| Caribou Biosciences, Inc. | -102.07 Million USD | -101.112% |
| CRISPR Therapeutics AG | -153.61 Million USD | -33.634% |
| Precision BioSciences, Inc. | -61.31 Million USD | -234.766% |
| Fate Therapeutics, Inc. | -160.92 Million USD | -27.557% |
| Innoviva, Inc. | 179.72 Million USD | 214.218% |
| Summit Therapeutics Inc. | -614.92 Million USD | 66.618% |
| Verrica Pharmaceuticals Inc. | -66.99 Million USD | -206.403% |
| Aadi Bioscience, Inc. | -65.76 Million USD | -212.134% |
| ESSA Pharma Inc. | -26.58 Million USD | -672.223% |
| GlycoMimetics, Inc. | -36.89 Million USD | -456.31% |
| GT Biopharma, Inc. | -7.59 Million USD | -2602.053% |
| Inhibrx Biosciences, Inc. | -241.36 Million USD | 14.951% |
| Catalyst Pharmaceuticals, Inc. | 71.41 Million USD | 387.46% |
| Orchestra BioMed Holdings, Inc. | -49.12 Million USD | -317.905% |
| Alzamend Neuro, Inc. | -9.94 Million USD | -1963.533% |
| Rocket Pharmaceuticals, Inc. | -245.59 Million USD | 16.417% |
| Aptose Biosciences Inc. | -51.2 Million USD | -300.873% |
| ZyVersa Therapeutics, Inc. | -98.29 Million USD | -108.829% |
| Soligenix, Inc. | -6.14 Million USD | -3242.844% |
| Century Therapeutics, Inc. | -136.67 Million USD | -50.194% |
| Kura Oncology, Inc. | -152.63 Million USD | -34.491% |
| TScan Therapeutics, Inc. | -89.21 Million USD | -130.082% |
| Intensity Therapeutics, Inc. | -10.53 Million USD | -1847.95% |
| Ocean Biomedical, Inc. | 565.47 Thousand USD | 36401.661% |
| CytomX Therapeutics, Inc. | -569 Thousand USD | -35976.45% |
| Autolus Therapeutics plc | -208.38 Million USD | 1.491% |
| Mineralys Therapeutics, Inc. | -71.89 Million USD | -185.509% |
| EyePoint Pharmaceuticals, Inc. | -70.79 Million USD | -189.957% |
| Eterna Therapeutics Inc. | -21.66 Million USD | -847.365% |
| Adaptive Biotechnologies Corporation | -225.25 Million USD | 8.868% |
| GRI Bio, Inc. | -13.03 Million USD | -1474.557% |
| Xenetic Biosciences, Inc. | -4.13 Million USD | -4864.836% |
| Tenaya Therapeutics, Inc. | -124.08 Million USD | -65.432% |
| IGM Biosciences, Inc. | -246.41 Million USD | 16.696% |
| INmune Bio, Inc. | -30 Million USD | -584.068% |
| Heron Therapeutics, Inc. | -110.55 Million USD | -85.67% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -386.505% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -1186.051% |
| Entero Therapeutics, Inc. | -15.79 Million USD | -1199.622% |
| Milestone Pharmaceuticals Inc. | -59.68 Million USD | -243.931% |
| X4 Pharmaceuticals, Inc. | -101.16 Million USD | -102.907% |
| Atara Biotherapeutics, Inc. | -276.12 Million USD | 25.659% |
| Coherus BioSciences, Inc. | -237.89 Million USD | 13.711% |
| Verastem, Inc. | -87.36 Million USD | -134.957% |
| Abeona Therapeutics Inc. | -54.18 Million USD | -278.82% |
| Pliant Therapeutics, Inc. | -161.33 Million USD | -27.234% |
| Tonix Pharmaceuticals Holding Corp. | -116.65 Million USD | -75.963% |
| Histogen Inc. | -10.62 Million USD | -1832.728% |
| Aprea Therapeutics, Inc. | -14.28 Million USD | -1336.82% |
| Surrozen, Inc. | -43.04 Million USD | -376.918% |
| Organovo Holdings, Inc. | -14.67 Million USD | -1299.189% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -3935.263% |
| Ovid Therapeutics Inc. | -52.33 Million USD | -292.203% |
| Panbela Therapeutics, Inc. | -25.26 Million USD | -712.552% |
| CASI Pharmaceuticals, Inc. | -26.93 Million USD | -662.028% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.35 Million USD | -2356.299% |
| Centessa Pharmaceuticals plc | -151.08 Million USD | -35.867% |
| Hepion Pharmaceuticals, Inc. | -48.92 Million USD | -319.562% |
| Arcturus Therapeutics Holdings Inc. | -29.72 Million USD | -590.58% |
| BioRestorative Therapies, Inc. | -10.41 Million USD | -1870.444% |
| Apollomics, Inc. | -172.6 Million USD | -18.93% |
| Amarin Corporation plc | -59.11 Million USD | -247.265% |
| Mesoblast Limited | -87.95 Million USD | -133.384% |
| Turnstone Biologics Corp. | -55.2 Million USD | -271.875% |
| Kymera Therapeutics, Inc. | -146.96 Million USD | -39.679% |
| Synaptogenix, Inc. | -6.03 Million USD | -3299.435% |
| Tiziana Life Sciences Ltd | -16.2 Million USD | -1166.504% |
| Aurinia Pharmaceuticals Inc. | -78.02 Million USD | -163.106% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -4184.179% |
| Monopar Therapeutics Inc. | -8.4 Million USD | -2343.111% |
| Exelixis, Inc. | 207.76 Million USD | 198.802% |
| Better Therapeutics, Inc. | -39.76 Million USD | -416.285% |
| Nurix Therapeutics, Inc. | -143.94 Million USD | -42.604% |
| Apellis Pharmaceuticals, Inc. | -528.62 Million USD | 61.168% |
| NLS Pharmaceutics AG | -12.17 Million USD | -1586.448% |
| Dermata Therapeutics, Inc. | -7.79 Million USD | -2533.524% |
| Aridis Pharmaceuticals, Inc. | -30.74 Million USD | -567.583% |
| Gritstone bio, Inc. | -138.49 Million USD | -48.224% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -218.429% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -5031.939% |
| Avid Bioservices, Inc. | -140.75 Million USD | -45.841% |
| Insmed Incorporated | -749.56 Million USD | 72.614% |
| Virpax Pharmaceuticals, Inc. | -15.18 Million USD | -1251.426% |
| MediWound Ltd. | -6.71 Million USD | -2956.507% |
| OmniAb, Inc. | -50.61 Million USD | -305.53% |
| Alector, Inc. | -130.39 Million USD | -57.43% |
| Seres Therapeutics, Inc. | -113.72 Million USD | -80.503% |
| Checkpoint Therapeutics, Inc. | -51.84 Million USD | -295.925% |
| Zai Lab Limited | -334.62 Million USD | 38.654% |
| Revance Therapeutics, Inc. | -323.98 Million USD | 36.641% |
| Aura Biosciences, Inc. | -76.4 Million USD | -168.656% |
| Lyell Immunopharma, Inc. | -234.63 Million USD | 12.512% |
| Immunic, Inc. | -93.61 Million USD | -119.283% |
| Tarsus Pharmaceuticals, Inc. | -135.89 Million USD | -51.056% |
| Veracyte, Inc. | -74.4 Million USD | -175.892% |
| InMed Pharmaceuticals Inc. | -7.67 Million USD | -2574.401% |
| FibroGen, Inc. | -284.23 Million USD | 27.779% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -682.537% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -2831.708% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.83 Million USD | -989.993% |
| Jazz Pharmaceuticals plc | 414.83 Million USD | 149.484% |
| Cyclacel Pharmaceuticals, Inc. | -22.55 Million USD | -810.109% |
| Amylyx Pharmaceuticals, Inc. | 49.27 Million USD | 516.624% |
| TG Therapeutics, Inc. | 12.67 Million USD | 1719.91% |
| Galecto, Inc. | -38.34 Million USD | -435.281% |
| Calithera Biosciences, Inc. | -18.86 Million USD | -988.068% |
| Fortrea Holdings Inc. | -3.4 Million USD | -5937.5% |
| KalVista Pharmaceuticals, Inc. | -126.64 Million USD | -62.088% |
| Aptevo Therapeutics Inc. | -17.41 Million USD | -1078.996% |
| XBiotech Inc. | -24.55 Million USD | -735.912% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -218.429% |
| Lyra Therapeutics, Inc. | -62.68 Million USD | -227.497% |
| Foghorn Therapeutics Inc. | -98.42 Million USD | -108.558% |
| Y-mAbs Therapeutics, Inc. | -21.42 Million USD | -858.02% |
| Theravance Biopharma, Inc. | -55.19 Million USD | -271.922% |
| Ultragenyx Pharmaceutical Inc. | -606.63 Million USD | 66.162% |
| Metagenomi, Inc. Common Stock | -68.25 Million USD | -200.747% |
| Vaxxinity, Inc. | -56.93 Thousand USD | -360449.057% |
| BioCryst Pharmaceuticals, Inc. | -226.53 Million USD | 9.386% |
| Gain Therapeutics, Inc. | -22.26 Million USD | -821.858% |
| Cartesian Therapeutics, Inc. | -219.71 Million USD | 6.57% |
| NexImmune, Inc. | -32.34 Million USD | -534.654% |
| Creative Medical Technology Holdings, Inc. | -5.28 Million USD | -3782.95% |
| Marker Therapeutics, Inc. | -14.04 Million USD | -1361.459% |
| Regeneron Pharmaceuticals, Inc. | 3.95 Billion USD | 105.192% |
| Chemomab Therapeutics Ltd. | -24.22 Million USD | -747.508% |
| Scopus BioPharma Inc. | -11.6 Million USD | -1668.114% |
| RAPT Therapeutics, Inc. | -116.79 Million USD | -75.752% |
| Ainos, Inc. | -13.77 Million USD | -1390.681% |
| Pluri Inc. | -20.88 Million USD | -882.741% |
| Prothena Corporation plc | -147.02 Million USD | -39.616% |
| Adaptimmune Therapeutics plc | -113.87 Million USD | -80.27% |
| Celularity Inc. | -196.29 Million USD | -4.575% |
| Rallybio Corporation | -74.56 Million USD | -175.3% |
| Cue Biopharma, Inc. | -50.73 Million USD | -304.618% |
| MeiraGTx Holdings plc | -84.02 Million USD | -144.296% |
| Omeros Corporation | -117.81 Million USD | -74.238% |
| Humacyte, Inc. | -110.77 Million USD | -85.306% |
| Immunocore Holdings plc | -55.28 Million USD | -271.29% |
| Cocrystal Pharma, Inc. | -17.98 Million USD | -1041.431% |
| Cidara Therapeutics, Inc. | -22.93 Million USD | -795.186% |
| Blueprint Medicines Corporation | -506.98 Million USD | 59.511% |
| CalciMedica, Inc. | -34.35 Million USD | -497.476% |
| Cabaletta Bio, Inc. | -67.67 Million USD | -203.325% |
| Marinus Pharmaceuticals, Inc. | -141.4 Million USD | -45.168% |
| Scholar Rock Holding Corporation | -165.78 Million USD | -23.817% |
| Sana Biotechnology, Inc. | -283.25 Million USD | 27.53% |
| Pulmatrix, Inc. | -14.12 Million USD | -1353.686% |
| Elicio Therapeutics, Inc. | -35.19 Million USD | -483.25% |
| Vigil Neuroscience, Inc. | -82.63 Million USD | -148.403% |
| Intellia Therapeutics, Inc. | -481.19 Million USD | 57.34% |
| Adlai Nortye Ltd. American Depositary Shares | -104.87 Million USD | -95.74% |
| Cytokinetics, Incorporated | -526.24 Million USD | 60.992% |
| Eloxx Pharmaceuticals, Inc. | -36.06 Million USD | -469.181% |
| Nutriband Inc. | -5.48 Million USD | -3642.265% |
| Protara Therapeutics, Inc. | -40.42 Million USD | -407.855% |
| Vor Biopharma Inc. | -117.86 Million USD | -74.164% |
| Roivant Sciences Ltd. | 4.34 Billion USD | 104.72% |
| Evogene Ltd. | -23.87 Million USD | -759.647% |
| ProKidney Corp. | -35.46 Million USD | -478.761% |
| Applied Therapeutics, Inc. | -119.76 Million USD | -71.401% |
| Hoth Therapeutics, Inc. | -7.84 Million USD | -2516.505% |
| BridgeBio Pharma, Inc. | -643.2 Million USD | 68.085% |
| CorMedix Inc. | -46.33 Million USD | -342.983% |
| BioLineRx Ltd. | -60.61 Million USD | -238.659% |
| Tango Therapeutics, Inc. | -101.74 Million USD | -101.756% |
| Galectin Therapeutics Inc. | -41.06 Million USD | -399.866% |
| Atai Life Sciences N.V. | -40.22 Million USD | -410.33% |
| Renovaro Biosciences Inc. | -80.65 Million USD | -154.525% |
| Aerovate Therapeutics, Inc. | -75.52 Million USD | -171.812% |
| Zentalis Pharmaceuticals, Inc. | -292.19 Million USD | 29.746% |
| Sagimet Biosciences Inc. | -27.87 Million USD | -636.386% |
| MediciNova, Inc. | -8.57 Million USD | -2294.851% |
| Praxis Precision Medicines, Inc. | -123.27 Million USD | -66.515% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -2350.508% |
| GeoVax Labs, Inc. | -25.96 Million USD | -690.53% |
| Axsome Therapeutics, Inc. | -239.23 Million USD | 14.196% |
| Biomea Fusion, Inc. | -117.25 Million USD | -75.067% |
| PTC Therapeutics, Inc. | -626.6 Million USD | 67.24% |
| Mereo BioPharma Group plc | -29.46 Million USD | -596.65% |
| Cullinan Oncology, Inc. | -153.16 Million USD | -34.025% |
| Syndax Pharmaceuticals, Inc. | -209.36 Million USD | 1.951% |
| Absci Corporation | -110.56 Million USD | -85.658% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -580.846% |
| 4D Molecular Therapeutics, Inc. | -100.83 Million USD | -103.571% |
| Dyne Therapeutics, Inc. | -235.93 Million USD | 12.996% |
| Kiniksa Pharmaceuticals, Ltd. | 14.08 Million USD | 1557.505% |
| Ventyx Biosciences, Inc. | -192.96 Million USD | -6.381% |
| Allakos Inc. | -185.7 Million USD | -10.541% |
| Imunon, Inc. | -19.51 Million USD | -951.884% |
| Fulcrum Therapeutics, Inc. | -97.33 Million USD | -110.895% |
| Corcept Therapeutics Incorporated | 106.14 Million USD | 293.4% |
| BioAtla, Inc. | -123.46 Million USD | -66.266% |
| NLS Pharmaceutics AG | -12.17 Million USD | -1586.448% |
| Bio-Path Holdings, Inc. | -16.07 Million USD | -1176.745% |
| Allogene Therapeutics, Inc. | -327.26 Million USD | 37.276% |
| Larimar Therapeutics, Inc. | -36.94 Million USD | -455.563% |
| XOMA Corporation | -40.83 Million USD | -402.743% |
| Kezar Life Sciences, Inc. | -101.87 Million USD | -101.507% |
| Cara Therapeutics, Inc. | -118.51 Million USD | -73.209% |
| aTyr Pharma, Inc. | -50.38 Million USD | -307.381% |
| Aligos Therapeutics, Inc. | -87.67 Million USD | -134.121% |
| Akero Therapeutics, Inc. | -151.75 Million USD | -35.264% |
| Viridian Therapeutics, Inc. | -237.73 Million USD | 13.653% |
| Eliem Therapeutics, Inc. | -35.11 Million USD | -484.513% |
| EyeGate Pharmaceuticals, Inc. | -8.09 Million USD | -2436.784% |
| Akari Therapeutics, Plc | -10 Million USD | -1951.109% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -304801.597% |
| Halozyme Therapeutics, Inc. | 281.59 Million USD | 172.898% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -2979.942% |
| UroGen Pharma Ltd. | -102.24 Million USD | -100.77% |
| Sutro Biopharma, Inc. | -106.79 Million USD | -92.218% |
| ZIVO Bioscience, Inc. | -7.77 Million USD | -2539.452% |
| Orgenesis Inc. | -55.36 Million USD | -270.794% |
| Entera Bio Ltd. | -8.88 Million USD | -2209.315% |
| GH Research PLC | -35.58 Million USD | -476.826% |
| Lisata Therapeutics, Inc. | -20.84 Million USD | -885.005% |
| Reneo Pharmaceuticals, Inc. | -77.38 Million USD | -165.254% |
| Xencor, Inc. | -126.08 Million USD | -62.804% |
| 60 Degrees Pharmaceuticals, Inc. | -3.76 Million USD | -5351.175% |
| Replimune Group, Inc. | -215.79 Million USD | 4.875% |
| Coeptis Therapeutics Holdings, Inc. | -21.26 Million USD | -865.249% |
| Vanda Pharmaceuticals Inc. | 2.5 Million USD | 8281.546% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -2979.942% |
| Portage Biotech Inc. | -75.33 Million USD | -172.468% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -2350.508% |
| Olema Pharmaceuticals, Inc. | -96.65 Million USD | -112.379% |
| OncoCyte Corporation | -27.78 Million USD | -638.904% |
| Qualigen Therapeutics, Inc. | -13.41 Million USD | -1429.938% |
| Processa Pharmaceuticals, Inc. | -11.12 Million USD | -1745.746% |
| Purple Biotech Ltd. | -19.88 Million USD | -932.57% |
| CollPlant Biotechnologies Ltd. | -7.01 Million USD | -2824.562% |
| scPharmaceuticals Inc. | -54.81 Million USD | -274.521% |
| ProMIS Neurosciences, Inc. | -17.5 Million USD | -1072.588% |
| HilleVax, Inc. | -123.56 Million USD | -66.126% |
| NeuroSense Therapeutics Ltd. | -10.1 Million USD | -1931.018% |
| Tharimmune, Inc. | -9.31 Million USD | -2102.736% |
| Genprex, Inc. | -30.86 Million USD | -565.172% |
| Neumora Therapeutics, Inc. Common Stock | -235.92 Million USD | 12.991% |
| Atossa Therapeutics, Inc. | -30.09 Million USD | -582.113% |
| XTL Biopharmaceuticals Ltd. | -1.78 Million USD | -11419.36% |
| Virios Therapeutics, Inc. | -5.29 Million USD | -3776.028% |
| OKYO Pharma Limited | -16.82 Thousand USD | -1219926.08% |
| Savara Inc. | -54.69 Million USD | -275.288% |
| Curis, Inc. | -47.41 Million USD | -332.951% |
| Daré Bioscience, Inc. | -30.16 Million USD | -580.589% |
| Carmell Therapeutics Corporation | -15.44 Million USD | -1229.063% |
| Titan Pharmaceuticals, Inc. | -5.56 Million USD | -3586.03% |
| Achieve Life Sciences, Inc. | -29.81 Million USD | -588.496% |
| BeiGene, Ltd. | -881.7 Million USD | 76.718% |
| Kiromic BioPharma, Inc. | -21.29 Million USD | -864.004% |
| Revolution Medicines, Inc. Warrant | -436.36 Million USD | 52.958% |
| Protagonist Therapeutics, Inc. | -78.95 Million USD | -159.99% |
| Erasca, Inc. | -125.04 Million USD | -64.165% |
| bluebird bio, Inc. | -211.91 Million USD | 3.132% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -4005.092% |
| BioMarin Pharmaceutical Inc. | 167.64 Million USD | 222.446% |
| DBV Technologies S.A. | -72.72 Million USD | -182.258% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -4005.092% |
| Moderna, Inc. | -4.71 Billion USD | 95.645% |
| Vincerx Pharma, Inc. | -40.15 Million USD | -411.181% |
| Fresh Tracks Therapeutics, Inc. | -5.69 Million USD | -3505.111% |
| Molecular Templates, Inc. | -8.12 Million USD | -2426.773% |
| Acrivon Therapeutics, Inc. Common Stock | -60.38 Million USD | -239.927% |
| Travere Therapeutics, Inc. | -111.39 Million USD | -84.27% |
| Monte Rosa Therapeutics, Inc. | -135.35 Million USD | -51.66% |
| Spruce Biosciences, Inc. | -47.91 Million USD | -328.379% |
| Celldex Therapeutics, Inc. | -141.42 Million USD | -45.143% |
| Cogent Biosciences, Inc. | -192.41 Million USD | -6.686% |
| MacroGenics, Inc. | -9.05 Million USD | -2166.229% |
| RenovoRx, Inc. | -10.23 Million USD | -1906.206% |
| Adicet Bio, Inc. | -142.65 Million USD | -43.893% |
| Prime Medicine, Inc. | -198.13 Million USD | -3.605% |
| Aditxt, Inc. | -32.38 Million USD | -533.94% |
| Adagene Inc. | -18.94 Million USD | -983.453% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -2707.478% |
| Quantum-Si incorporated | -95.96 Million USD | -113.917% |
| Maravai LifeSciences Holdings, Inc. | -119.02 Million USD | -72.458% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -1308.137% |
| Voyager Therapeutics, Inc. | 132.33 Million USD | 255.124% |
| SciSparc Ltd. | -5.12 Million USD | -3907.712% |
| Vericel Corporation | -3.18 Million USD | -6351.131% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -170601.182% |
| Minerva Neurosciences, Inc. | -30 Million USD | -584.128% |
| Generation Bio Co. | -126.61 Million USD | -62.129% |
| Astria Therapeutics, Inc. | -72.89 Million USD | -181.619% |
| Black Diamond Therapeutics, Inc. | -82.44 Million USD | -148.993% |
| Arcutis Biotherapeutics, Inc. | -262.14 Million USD | 21.693% |
| Invivyd, Inc. | -198.64 Million USD | -3.339% |
| Relay Therapeutics, Inc. | -341.97 Million USD | 39.973% |
| Quoin Pharmaceuticals, Ltd. | -8.68 Million USD | -2263.13% |
| Spero Therapeutics, Inc. | 22.8 Million USD | 1000.092% |
| Artelo Biosciences, Inc. | -9.87 Million USD | -1978.945% |
| 2seventy bio, Inc. | -217.57 Million USD | 5.651% |
| ADMA Biologics, Inc. | -28.23 Million USD | -626.92% |
| Clene Inc. | -49.5 Million USD | -314.663% |
| Capricor Therapeutics, Inc. | -22.28 Million USD | -821.03% |
| Boundless Bio, Inc. Common Stock | -49.43 Million USD | -315.251% |
| GeoVax Labs, Inc. | -25.96 Million USD | -690.53% |
| Recursion Pharmaceuticals, Inc. | -328.06 Million USD | 37.429% |
| Citius Pharmaceuticals, Inc. | -32.54 Million USD | -530.783% |
| Contineum Therapeutics, Inc. Class A Common Stock | 22.72 Million USD | 1003.499% |
| Relmada Therapeutics, Inc. | -98.79 Million USD | -107.786% |
| Finch Therapeutics Group, Inc. | -74.75 Million USD | -174.601% |
| ALX Oncology Holdings Inc. | -160.8 Million USD | -27.655% |
| Vir Biotechnology, Inc. | -615.06 Million USD | 66.625% |
| Evaxion Biotech A/S | -22.12 Million USD | -827.797% |
| Ocular Therapeutix, Inc. | -80.73 Million USD | -154.255% |
| Verve Therapeutics, Inc. | -200.06 Million USD | -2.603% |
| Trevena, Inc. | -40.28 Million USD | -409.506% |
| Surrozen, Inc. | -43.04 Million USD | -376.918% |
| Tyra Biosciences, Inc. | -69.13 Million USD | -196.923% |
| Cingulate Inc. | -23.53 Million USD | -772.214% |
| Galmed Pharmaceuticals Ltd. | -6.91 Million USD | -2869.835% |
| Unity Biotechnology, Inc. | -39.86 Million USD | -414.99% |
| Tenax Therapeutics, Inc. | -7.71 Million USD | -2562.219% |
| Terns Pharmaceuticals, Inc. | -90.21 Million USD | -127.552% |
| ACADIA Pharmaceuticals Inc. | -61.28 Million USD | -234.946% |
| Connect Biopharma Holdings Limited | -59.5 Million USD | -244.983% |
| Clearmind Medicine Inc. | -11.95 Million USD | -1617.06% |
| Kronos Bio, Inc. | -112.67 Million USD | -82.187% |
| Bolt Biotherapeutics, Inc. | -69.19 Million USD | -196.653% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -8093606.012% |
| Viking Therapeutics, Inc. | -85.89 Million USD | -138.984% |
| Statera Biopharma, Inc. | -174.4 Million USD | -17.698% |
| ImmunityBio, Inc. | -583.19 Million USD | 64.802% |
| Korro Bio, Inc. | -81.17 Million USD | -152.889% |
| Kineta, Inc. | -14.09 Million USD | -1355.954% |
| BioVie Inc. | -32.12 Million USD | -539.077% |
| Codexis, Inc. | -76.24 Million USD | -169.248% |
| Celularity Inc. | -196.29 Million USD | -4.575% |
| Crinetics Pharmaceuticals, Inc. | -214.52 Million USD | 4.314% |
| Celcuity Inc. | -63.77 Million USD | -221.853% |
| Virax Biolabs Group Limited | -6.73 Million USD | -2948.546% |
| Cibus, Inc. | -267.62 Million USD | 23.298% |
| Eledon Pharmaceuticals, Inc. | -40.32 Million USD | -409.039% |
| eFFECTOR Therapeutics, Inc. | -35.81 Million USD | -473.218% |
| IN8bio, Inc. | -30 Million USD | -584.09% |
| Kodiak Sciences Inc. | -260.49 Million USD | 21.197% |
| Annexon, Inc. | -134.23 Million USD | -52.92% |
| Adverum Biotechnologies, Inc. | -117.16 Million USD | -75.202% |
| Assembly Biosciences, Inc. | -61.22 Million USD | -235.263% |
| Avalo Therapeutics, Inc. | -31.54 Million USD | -550.758% |
| Ionis Pharmaceuticals, Inc. | -366.28 Million USD | 43.958% |
| Eyenovia, Inc. | -27.26 Million USD | -652.996% |
| Puma Biotechnology, Inc. | 21.59 Million USD | 1050.743% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -38269.159% |
| Xilio Therapeutics, Inc. | -76.4 Million USD | -168.67% |
| Arcellx, Inc. | -70.69 Million USD | -190.388% |
| Cardiff Oncology, Inc. | -41.44 Million USD | -395.343% |
| Enanta Pharmaceuticals, Inc. | -133.81 Million USD | -53.401% |
| Regulus Therapeutics Inc. | -30.03 Million USD | -583.407% |
| Moolec Science SA | -51.78 Million USD | -296.369% |
| Acumen Pharmaceuticals, Inc. | -52.37 Million USD | -291.963% |
| Geron Corporation | -184.12 Million USD | -11.486% |
| LAVA Therapeutics N.V. | -41.97 Million USD | -389.053% |
| Royalty Pharma plc | 1.13 Billion USD | 118.089% |
| Atea Pharmaceuticals, Inc. | -135.95 Million USD | -50.986% |
| Greenwich LifeSciences, Inc. | -8.89 Million USD | -2208.587% |
| TFF Pharmaceuticals, Inc. | -21.24 Million USD | -866.308% |
| Mersana Therapeutics, Inc. | -171.67 Million USD | -19.575% |
| Humacyte, Inc. | -110.77 Million USD | -85.306% |
| Structure Therapeutics Inc. | -89.62 Million USD | -129.05% |
| 89bio, Inc. | -142.18 Million USD | -44.368% |
| PMV Pharmaceuticals, Inc. | -68.96 Million USD | -197.673% |
| Avenue Therapeutics, Inc. | -10.37 Million USD | -1878.173% |
| Genelux Corporation | -28.29 Million USD | -625.43% |
| Trevi Therapeutics, Inc. | -29.06 Million USD | -606.262% |
| Lexicon Pharmaceuticals, Inc. | -177.11 Million USD | -15.897% |
| Notable Labs, Ltd. | -11.26 Million USD | -1722.399% |
| Liquidia Corporation | -78.5 Million USD | -161.49% |
| Mustang Bio, Inc. | -51.6 Million USD | -297.804% |
| Immunovant, Inc. | -259.33 Million USD | 20.846% |
| Quantum-Si incorporated | -95.96 Million USD | -113.917% |
| Arbutus Biopharma Corporation | -72.84 Million USD | -181.781% |
| DiaMedica Therapeutics Inc. | -19.38 Million USD | -959.156% |
| Vera Therapeutics, Inc. | -95.99 Million USD | -113.85% |
| Acasti Pharma Inc. | -12.85 Million USD | -1497.098% |
| MiNK Therapeutics, Inc. | -22.45 Million USD | -814.045% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -1186.051% |
| Xenon Pharmaceuticals Inc. | -182.39 Million USD | -12.545% |
| Elevai Labs, Inc. Common Stock | -4.3 Million USD | -4672.154% |
| NeuroBo Pharmaceuticals, Inc. | -12.47 Million USD | -1546.151% |
| Tempest Therapeutics, Inc. | -29.49 Million USD | -596.06% |
| Soleno Therapeutics, Inc. | -38.98 Million USD | -426.508% |
| PepGen Inc. | -78.62 Million USD | -161.078% |
| Moleculin Biotech, Inc. | -29.76 Million USD | -589.56% |
| United Therapeutics Corporation | 984.8 Million USD | 120.844% |
| Nuvectis Pharma, Inc. | -22.26 Million USD | -822.17% |
| Solid Biosciences Inc. | -96.01 Million USD | -113.795% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -4184.179% |
| Immuneering Corporation | -53.47 Million USD | -283.895% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -3935.263% |
| Silo Pharma, Inc. | -3.7 Million USD | -5446.949% |
| Belite Bio, Inc | -31.63 Million USD | -548.947% |
| XOMA Corporation | -40.83 Million USD | -402.743% |
| ARS Pharmaceuticals, Inc. | -54.36 Million USD | -277.587% |
| Bionomics Limited | -15.49 Billion USD | 98.675% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -144.419% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -604.033% |
| uniQure N.V. | -308.47 Million USD | 33.456% |
| Cassava Sciences, Inc. | -97.21 Million USD | -111.151% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -2707.478% |
| Poseida Therapeutics, Inc. | -123.43 Million USD | -66.309% |
| Forte Biosciences, Inc. | -31.47 Million USD | -552.164% |
| Anebulo Pharmaceuticals, Inc. | -8.2 Million USD | -2402.834% |
| Enlivex Therapeutics Ltd. | -29.06 Million USD | -606.189% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -38269.159% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -682.537% |
| FibroBiologics, Inc. Common Stock | -16.48 Million USD | -1145.223% |
| Altimmune, Inc. | -88.44 Million USD | -132.088% |
| Amicus Therapeutics, Inc. | -151.58 Million USD | -35.42% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -604.033% |
| Compugen Ltd. | -18.75 Million USD | -994.566% |
| Peak Bio, Inc. | -1259.26 USD | -16301140.411% |
| Zevra Therapeutics, Inc. | -46.04 Million USD | -345.775% |
| Benitec Biopharma Inc. | -21.75 Million USD | -843.75% |
| Spyre Therapeutics, Inc. | -338.79 Million USD | 39.409% |
| NKGen Biotech, Inc. Common Stock | -82.95 Million USD | -147.456% |
| Zura Bio Limited | -60.36 Million USD | -240.084% |
| PolyPid Ltd. | -23.86 Million USD | -760.151% |
| Aileron Therapeutics, Inc. | -15.73 Million USD | -1204.825% |
| NKGen Biotech, Inc. Warrants | -82.95 Million USD | -147.456% |
| Instil Bio, Inc. | -156.08 Million USD | -31.513% |
| argenx SE | -295.05 Million USD | 30.428% |
| Immunome, Inc. | -106.8 Million USD | -92.194% |
| Compass Therapeutics, Inc. | -42.49 Million USD | -383.068% |
| Verona Pharma plc | -54.36 Million USD | -277.559% |
| enGene Holdings Inc. Warrants | -99.91 Million USD | -105.446% |
| Shattuck Labs, Inc. | -87.29 Million USD | -135.143% |
| CervoMed Inc. | -2.17 Million USD | -9351.519% |
| LENZ Therapeutics, Inc. | -124.65 Million USD | -64.68% |
| Plus Therapeutics, Inc. | -13.31 Million USD | -1441.567% |
| Dianthus Therapeutics, Inc. | -43.55 Million USD | -371.301% |
| Moolec Science SA | -51.78 Million USD | -296.369% |
| Enveric Biosciences, Inc. | -17.29 Thousand USD | -1187028.182% |
| Inovio Pharmaceuticals, Inc. | -135.11 Million USD | -51.923% |
| AnaptysBio, Inc. | -163.61 Million USD | -25.459% |
| Design Therapeutics, Inc. | -66.86 Million USD | -207.013% |
| Leap Therapeutics, Inc. | -81.41 Million USD | -152.137% |
| NeurAxis, Inc. | -14.62 Million USD | -1303.428% |
| Seelos Therapeutics, Inc. | -37.88 Million USD | -441.88% |
| Lumos Pharma, Inc. | -34.03 Million USD | -503.147% |
| Achilles Therapeutics plc | -69.66 Million USD | -194.66% |
| enGene Holdings Inc. Common Stock | -99.91 Million USD | -105.446% |
| 180 Life Sciences Corp. | -19.93 Million USD | -929.716% |
| Opiant Pharmaceuticals, Inc. | 3 Million USD | 6922.51% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -8093606.012% |
| Nutriband Inc. | -5.48 Million USD | -3642.265% |
| ORIC Pharmaceuticals, Inc. | -100.69 Million USD | -103.854% |
| CG Oncology, Inc. Common stock | -48.6 Million USD | -322.316% |
| Fractyl Health, Inc. Common Stock | -77.09 Million USD | -166.276% |
| Rani Therapeutics Holdings, Inc. | -33.97 Million USD | -504.283% |
| MoonLake Immunotherapeutics | -36 Million USD | -470.093% |
| Palisade Bio, Inc. | -12.3 Million USD | -1568.902% |
| Tourmaline Bio, Inc. | -42.12 Million USD | -387.311% |
| Beam Therapeutics Inc. | -132.52 Million USD | -54.893% |
| Neurogene Inc. | -36.31 Million USD | -465.231% |
| Mirum Pharmaceuticals, Inc. | -163.41 Million USD | -25.616% |
| AEON Biopharma, Inc. | -52.55 Million USD | -290.583% |
| CARGO Therapeutics, Inc. Common Stock | -98.14 Million USD | -109.151% |
| Sesen Bio, Inc. | -19.88 Million USD | -932.363% |
| Enliven Therapeutics, Inc. | -71.58 Million USD | -186.761% |
| Kiora Pharmaceuticals, Inc. | -12.51 Million USD | -1540.376% |
| Iovance Biotherapeutics, Inc. | -444.03 Million USD | 53.771% |
| Taysha Gene Therapies, Inc. | -111.56 Million USD | -83.994% |
| Athira Pharma, Inc. | -117.67 Million USD | -74.447% |
| Vaccinex, Inc. | -20.25 Million USD | -913.654% |
| HCW Biologics Inc. | -24.99 Million USD | -721.288% |
| XOMA Corporation | -40.83 Million USD | -402.743% |
| Nektar Therapeutics | -276.05 Million USD | 25.64% |
| Arvinas, Inc. | -367.3 Million USD | 44.112% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -304801.597% |
| Merus N.V. | -154.93 Million USD | -32.488% |
| Omega Therapeutics, Inc. | -97.42 Million USD | -110.694% |
| Quince Therapeutics, Inc. | -31.38 Million USD | -554.054% |
| Rezolute, Inc. | -68.45 Million USD | -199.851% |
| Clene Inc. | -49.5 Million USD | -314.663% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -1230.926% |
| BeyondSpring Inc. | -21.02 Million USD | -876.291% |
| Synlogic, Inc. | -57.28 Million USD | -258.359% |
| Allarity Therapeutics, Inc. | -11.9 Million USD | -1624.855% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -1796.13% |
| Peak Bio, Inc. | -1259.26 USD | -16301140.411% |
| Werewolf Therapeutics, Inc. | -37.36 Million USD | -449.334% |
| Krystal Biotech, Inc. | 10.93 Million USD | 1977.744% |
| Karyopharm Therapeutics Inc. | -143.09 Million USD | -43.45% |
| SpringWorks Therapeutics, Inc. | -325.1 Million USD | 36.859% |
| Lipella Pharmaceuticals Inc. | -4.61 Million USD | -4344.177% |
| MannKind Corporation | -11.93 Million USD | -1619.509% |
| Ikena Oncology, Inc. | -68.16 Million USD | -201.14% |
| Cyclerion Therapeutics, Inc. | -21.01 Million USD | -876.802% |
| Gyre Therapeutics, Inc. | -92.93 Million USD | -120.885% |
| Gossamer Bio, Inc. | -179.81 Million USD | -14.158% |
| CohBar, Inc. | -11.96 Million USD | -1616.042% |
| Cognition Therapeutics, Inc. | -25.78 Million USD | -696.01% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -580.846% |
| Legend Biotech Corporation | -518.25 Million USD | 60.391% |
| Mural Oncology plc | -207.44 Million USD | 1.047% |
| Biora Therapeutics, Inc. | -124.11 Million USD | -65.391% |
| PaxMedica, Inc. Common Stock | -18.28 Million USD | -1022.351% |
| Disc Medicine, Inc. | -76.42 Million USD | -168.583% |
| Champions Oncology, Inc. | -7.27 Million USD | -2721.262% |
| REGENXBIO Inc. | -263.49 Million USD | 22.095% |
| Ensysce Biosciences, Inc. | -10.61 Million USD | -1834.171% |
| Anavex Life Sciences Corp. | -47.5 Million USD | -332.112% |
| Cellectar Biosciences, Inc. | -37.98 Million USD | -440.432% |
| Edgewise Therapeutics, Inc. | -100.16 Million USD | -104.941% |
| Vaxart, Inc. | -82.46 Million USD | -148.924% |
| PharmaCyte Biotech, Inc. | 333.76 Thousand USD | 61603.222% |
| Aldeyra Therapeutics, Inc. | -37.54 Million USD | -446.78% |
| Cellectis S.A. | -101.05 Million USD | -103.124% |
| Longeveron Inc. | -21.41 Million USD | -858.647% |
| Repare Therapeutics Inc. | -93.79 Million USD | -118.853% |
| Sarepta Therapeutics, Inc. | -535.97 Million USD | 61.701% |
| Inozyme Pharma, Inc. | -71.16 Million USD | -188.433% |
| Revolution Medicines, Inc. | -436.36 Million USD | 52.958% |
| Nymox Pharmaceutical Corporation | -6.57 Million USD | -3023.954% |
| Third Harmonic Bio, Inc. | -30.82 Million USD | -565.958% |
| ArriVent BioPharma, Inc. Common Stock | -69.33 Million USD | -196.071% |
| AN2 Therapeutics, Inc. | -64.73 Million USD | -217.115% |
| Anixa Biosciences, Inc. | -9.81 Million USD | -1992.294% |
| Vertex Pharmaceuticals Incorporated | 3.61 Billion USD | 105.671% |
| Denali Therapeutics Inc. | -145.22 Million USD | -41.351% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -170601.182% |
| Veru Inc. | -93.15 Million USD | -120.364% |
| Corvus Pharmaceuticals, Inc. | -27.02 Million USD | -659.462% |
| Cingulate Inc. | -23.53 Million USD | -772.214% |
| Passage Bio, Inc. | -102.06 Million USD | -101.128% |
| Context Therapeutics Inc. | -23.96 Million USD | -756.59% |
| Exicure, Inc. | -16.91 Million USD | -1113.64% |
| Day One Biopharmaceuticals, Inc. | -188.91 Million USD | -8.659% |
| Oramed Pharmaceuticals Inc. | -37.76 Million USD | -443.573% |
| Scinai Immunotherapeutics Ltd. | -6.5 Million USD | -3054.522% |
| Rhythm Pharmaceuticals, Inc. | -184.67 Million USD | -11.153% |
| Nuvalent, Inc. | -126.21 Million USD | -62.634% |
| ABVC BioPharma, Inc. | -10.51 Million USD | -1852.089% |
| Carisma Therapeutics, Inc. | -86.87 Million USD | -136.277% |
| Unicycive Therapeutics, Inc. | -30.54 Million USD | -572.063% |
| OmniAb, Inc. | -50.61 Million USD | -305.53% |
| Anew Medical, Inc. | 1.34 Million USD | 15349.327% |
| Fennec Pharmaceuticals Inc. | -16.04 Million USD | -1179.371% |
| Lipocine Inc. | -16.35 Million USD | -1155.345% |
| Lexeo Therapeutics, Inc. Common Stock | -66.39 Million USD | -209.177% |
| Nautilus Biotechnology, Inc. | -63.67 Million USD | -222.379% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -386.505% |
| G1 Therapeutics, Inc. | -47.96 Million USD | -327.95% |
| Bellerophon Therapeutics, Inc. | -19.83 Million USD | -935.122% |
| Sage Therapeutics, Inc. | -541.48 Million USD | 62.091% |
| Ocugen, Inc. | -63.07 Million USD | -225.43% |
| Mind Medicine (MindMed) Inc. | -95.73 Million USD | -114.427% |
| Q32 Bio Inc. | -112.96 Million USD | -81.722% |
| Brainstorm Cell Therapeutics Inc. | -17.19 Million USD | -1094.015% |
| Alumis Inc. Common Stock | -154.99 Million USD | -32.441% |
| Equillium, Inc. | -13.33 Million USD | -1439.37% |
| Kyverna Therapeutics, Inc. | -60.36 Million USD | -240.051% |
| Coya Therapeutics, Inc. | -7.98 Million USD | -2469.845% |
| CNS Pharmaceuticals, Inc. | -18.85 Million USD | -988.921% |
| Galera Therapeutics, Inc. | -59.08 Million USD | -247.441% |
| Evelo Biosciences, Inc. | -114.52 Million USD | -79.237% |
| Comera Life Sciences Holdings, Inc. | -18.37 Million USD | -1016.963% |
| Dominari Holdings Inc. | -22.88 Million USD | -797.103% |
| Edesa Biotech, Inc. | -8.37 Million USD | -2351.216% |
| vTv Therapeutics Inc. | -20.25 Million USD | -913.704% |
| Bio-Techne Corporation | 168.1 Million USD | 222.111% |
| Agios Pharmaceuticals, Inc. | -352.08 Million USD | 41.698% |
| Harmony Biosciences Holdings, Inc. | 128.85 Million USD | 259.309% |
| Prelude Therapeutics Incorporated | -121.83 Million USD | -68.49% |
| Candel Therapeutics, Inc. | -37.93 Million USD | -441.066% |
| iTeos Therapeutics, Inc. | -112.64 Million USD | -82.237% |
| Nkarta, Inc. | -117.5 Million USD | -74.701% |
| BioCardia, Inc. | -11.57 Million USD | -1674.047% |
| Iterum Therapeutics plc | -38.37 Million USD | -434.974% |